Stimulation of fibroblasts with platelet-derived growth factor, which activates SREBP-1, had a similar effect. Fasted mice that were refed with a high carbohydrate diet presented an increased expression of HMOX1 and p55γ in the liver. Overall, the transcriptional signature of SREBP-1 in fibroblasts stimulated by growth factors was very similar to that described in liver cells. We analyzed the HMOX1 promoter and found one SREBP binding site of the Ebox type, which was required for regulation by SREBP-1a and SREBP-1c, but was insensitive to SREBP-2. In conclusion, our data suggest that SREBP-1 regulates the expression of stress response and signaling genes, which could contribute to the metabolic response to insulin and growth factors in various tissues.
SREBPs are key regulators of lipid metabolism in vivo. In the liver and the adipose tissue, SREBP-1c expression is strongly induced by dietary glucose and insulin (4, 5) . In addition, it was suggested that insulin stimulates the processing of the SREBP-1 precursor and increases the stability of mature SREBP-1 (6, 7) . SREBP-1c is responsible for lipid accumulation in the liver of mice that are fed with a high carbohydrate diet after fasting (4) .
The regulation of lipid metabolism by SREBPs is not restricted to liver cells. Early studies showed that SREBP processing is required for cell proliferation in lipid-free medium (8) . We and others have shown that growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor and IGF-I induce a strong accumulation of mature SREBPs in the nucleus of various cell types, resulting in an increased membrane lipid synthesis associated with cell growth (9, 10) . SREBP-1 has also been shown to be hyperphosphorylated and activated during mitosis (11) . Activation of SREBPs by growth factors and insulin is mediated by the activation of the phosphatidylinositol-3 kinase (PI3K) and its downstream effector, protein kinase B (AKT) (4, 9) .
A large number of genes regulated by SREBPs in liver cells have been identified by systematic analysis of the expression of lipid metabolism enzymes and by microarray studies by guest, on October 1, 2017 www.jlr.org Downloaded from in mice carrying a transgene encoding an activated form of SREBP (1, 12, 13) . SREBP-1c preferentially activates lipogenic genes (such as fatty acid synthase), while SREBP-2 acts more specifically on cholesterol biosynthesis genes (3). SREBP-1a regulates both metabolic pathways. In the present study, we analyzed gene regulation by SREBP-1 in fibroblasts.
Besides lipid metabolism genes, we found a number of SREBP-1-regulated transcripts that had not been connected to lipid metabolism before. These include heme oxygenase 1 and other stress response genes.
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MATERIALS AND METHODS
Cell culture and reagents
AG01518 human foreskin fibroblasts (Coriell Institute for Medical Research, Camden, NJ, USA) from passages 11 to 19 were cultured in modified Eagle medium (Sigma) supplemented with 10% foetal calf serum and glutamine. Cholesterol, 25-hydroxycholesterol, hemin and mevinolin were from Sigma. HepG2 cells were obtained from ATCC and cultured in Dulbecco's modified Eagle medium (Sigma) in the presence of 10% foetal calf serum. Active rat SREBP-1c and mock adenoviruses were described elsewhere (5). Constructs encoding active human SREBP-1a, human SREBP-2 and rat SREBP-1c/ADD1 were kindly provided by Johan Ericsson (Uppsala, Sweden).
cDNA microarray analysis
Subconfluent AG01518 fibroblasts were infected with adenoviruses encoding SREBP-1c or mock virus at 60 MOI per cell for 24 h, which was found to be optimal. Total RNA was isolated using the RNeasy kit (Qiagen) and used for microarray hybridizations as described (9, 14) . Briefly, total RNA (40 μg) from cells infected with SREBP-1c or mock viruses were labeled in reverse transcription reactions (Superscript II kit, Invitrogen) with dCTP-Cy5 and dCTP-Cy3, respectively (Amersham). Purified cDNA probes labeled with Cy3 and Cy5 were mixed per pair, and hybridized to cDNA microarray chips (Hver1.2.1) from the Sanger Institute/LICR/CRUK Consortium (see http://www.sanger.ac.uk/Projects/Microarrays/ for details and hybridization protocols). We performed three independent hybridizations, including one dye-swap control. Chips were scanned in a Perkin Elmer/GSI Lumonics ScanArray 4000 scanner and spot intensities were measured using the QuantArray software (histogram method with background subtraction).
Normalization and statistical analysis of the triplicate data sets were performed using GeneSpring 5.0 analysis software (Silicon Genetics). A LOWESS non-linear normalization was applied, and a statistical analysis of the data based on the global error model of GeneSpring was used. For all features selected using this protocol, the signal was significantly above the background, indicating that the expression of these genes was detectable. Finally, as Hver1.2.1 microarrays contain replicate spots (1 to 6) corresponding to the same gene, genes represented by spots that were not regulated in a similar manner were discarded. We show the average ratio of one representative spot for each regulated gene, with standard error calculated from three hybridizations and with the annotation provided by the microarray facility Quantitative real time PCR experiments were performed as described (9, 14) .
Animal experiments
All studies were approved by the institutional review boards for the care and use of experimental animals. Male mice (25 g; NMRI, Harlan, the Netherlands) were divided into two groups (6 mice per group) : fasted (control) and fasted/refed with a high carbohydrate diet 
Luciferase experiments
A fragment of the human HMOX1 promoter (311 base pairs including the transcription start) was amplified by PCR using the following oligonucleotides: 5'-TCAGATTTCCTTAAAGGTTTTGTGTG and 5'-CGAGAGGAGGCAGGCG. The PCR product was purified, digested with KpnI and HindIII (Fermentas) and cloned into pGL3basic (Promega). Mutants were produced using the Quickchange method (Stratagene). All constructs were verified by sequencing. HepG2 cells were seeded one day before transfection in 12 well plates (10 5 cells per well) and transfected with calcium phosphate precipitates, as described (9) . The indicated promoters cloned into the pGL3 luciferase reporter (250 ng, Promega), were mixed with pDRIVE-chEF1-RU5' (β−galactosidase reporter, Invitrogen, 250 ng) and pCDNA3 as carrier DNA. Cells were washed, incubated in medium for 40 hours, lysed and processed as described (9) . Data is presented as the average ratio between the luciferase activity and the β-galactosidase content. 
RESULTS
Gene regulation by SREBP-1 in human fibroblasts
Using cDNA microarrays, we have shown that growth factors activate SREBP-1 and induce the expression of SREBP-target genes in normal human fibroblasts (9) . To gain knowledge about gene regulation by SREBP-1 in fibroblasts, we expressed mature SREBP-1 in AG01518 fibroblasts. We infected these cells with an adenovirus encoding the active part of SREBP-1c [amino acids 1-403 (5)]. Figure 1 shows that, 24 hours after infection with the SREBP-1c virus, expression of stearoyl-coenzyme A desaturase (SCD) was strongly induced.
The control adenovirus had no effect compared to non-infected cells (not shown). We performed microarray analysis to identify other genes regulated by SREBP-1c. Cy3-and Cy5-labeled probes were prepared from RNA extracted from cells infected either with the control virus or with the SREBP-1c virus. These probes were hybridized onto Hver1.2.1 human cDNA microarrays provided by the Sanger Institute. We selected genes that were significantly regulated (p<0.05) at least two-fold based on the average of three independent experiments.
Among the genes selected using these criteria, we found six genes that are involved in fatty acid biosynthesis and that have previously been shown to be regulated by SREBP-1c in liver cells (Table I) . Another ten regulated genes are known targets of SREBP-1a and SREBP-2 (Table I ). It is likely that over-expression of SREBP-1c resulted in the activation of SREBP1a target genes in our model, since these two factors share an identical DNA binding domain.
The expression of most of these genes was increased more than three-fold. In conclusion, infection of fibroblasts with SREBP-1 adenoviruses induced the classical SREBP transcriptional signature described in hepatocytes.
We identified 11 other up-regulated genes directly involved in lipid metabolism, such as mitochondrial citrate and carboxylate transport proteins (SLC25A1 and SLC16A1), lipoprotein receptors (LRP8 and OLR1) and genes involved in phosphatidylethanolamine synthesis (PCYT2, PISD and PEBP1) (Table II) . These genes are likely novel targets of SREBP-1, although they are up-regulated to a lesser extent compared to known SREBP target genes. Interestingly, expression of the citrate transporter SLC25A1 was increased in transgenic mice for SREBP-1a and SREBP-2, and was decreased in SCAP-deficient mice, according to published microarray results [supplementary data in reference (13)].
A surprisingly large number of genes that were significantly up-regulated upon infection with the SREBP-1c virus are not directly related to lipid metabolism (Table III) .
Since most known SREBP target genes were induced more than three-fold, we considered only the 25 genes that passed this threshold. Five genes that are not directly connected to lipid metabolism were also down-regulated by SREBP-1c infection (data not shown). The induction of the top five up-regulated genes in this category (PIK3R3, SV2A, COTE1, GPx-3 and HMOX1) in AG01518 fibroblasts was confirmed by quantitative PCR ( Figure 1A) . None of these genes had previously been associated with lipid synthesis : PIK3R3 encodes the p55γ regulatory subunit of PI3K, an enzyme that plays a key role in insulin and growth factor signaling (16); synaptic vesicle glycoprotein 2A (SV2A) is associated with exocytosis in neurones and endocrine cells (17); COTE1 encodes a hydrophobic protein of unknown function; GPx-3 encodes plasma glutathion peroxidase and heme oxygenase 1 (HMOX1)
catalyses the degradation of heme into biliverdin, releasing iron and carbon monoxide (18) .
Interestingly, biliverdin reductase B, an enzyme that converts biliverdin into bilirubin, was found to be up-regulated in the liver of transgenic mice for SREBP-1a and SREBP-2 (13).
HMOX1, biliverdin reductase and GPx-3 exhibit strong antioxidant properties (18, 19) .
Gene regulation by sterols and growth factors
We next showed that the SREBP-1c adenovirus also induced the expression of the 
Regulation of HMOX1 and p55γ in vivo
To determine whether p55γ, SV2A, COTE1 and HMOX1 were regulated in vivo, fasted mice were re-fed with a high carbohydrate diet, which induces SREBP-1c expression and activation in the liver. We used a pool of RNA extracted from livers of 6 mice in each group to hybridize to mouse microarrays. Genes up-regulated to the highest extent (5-20 fold)
included long chain fatty acid elongase 5, fatty acid synthase, glycerol-3-phosphate acyltransferase and SREBP-1 (data not shown), which were all expected to be part of the lipogenic response (21) . HMOX1 was the only new common hit between the lists of genes regulated by SREBP-1 in mouse liver and in human fibroblasts. We confirmed the regulation of HMOX1 in the liver of mice that received a high carbohydrate diet by quantitative PCR (Figure 3) . The other selected genes were not represented on the mouse microarray, and were tested by quantitative PCR. PIK3R3/p55γ RNA was also increased, with an average of about two-fold. The expression of ribosomal protein gene 36B4, used as a control, was not changed.
SV2A and COTE1 RNA were not detected in the liver, and GPx-3 was not regulated in these experiments (data not shown). As a control, we measured by quantitative PCR the expression of SCD2, which was strongly induced in 3 out of 6 mice ( Figure 3) . Altogether, these data
show that the expression of HMOX1 and p55γ was correlated with SREBP-1c activation in vivo.
SREBP-1 activates the HMOX1 promoter
We next analysed the proximal promoters of the selected genes using Genomatix softwares (www.genomatix.de). Potential promoter regions were screened for SREBP binding sites that matched the Transfac matrices and that were conserved in mouse and human genes.
We found one potential E-box-type SREBP binding site in the HMOX1 promoter, which was conserved in rat, mouse, human, chimpanzee and chicken ( Figure 4A and data not shown).
Putative SRE sites were also found in PIK3R3 and GPx-3 promoters but were not conserved.
A 311 base pairs fragment of the human HMOX1 promoter including the E-box site and the (iii) all transcripts were also induced by stimulation of AG01518 fibroblasts with PDGF, which activates SREBP-1 (9); (iv) finally, expression of HMOX1 and p55γ was increased in the liver of fasted mice refed with a high carbohydrate diet, a condition know to activate SREBP-1c in vivo. GPx-3 expression was also regulated by SREBP-1c adenovirus and sterols, but not by PDGF. Although GPx-3 was expressed in the liver, it was not affected by the carbohydrate diet, suggesting that the regulation of this gene is more complex.
The promoter region of the HMOX1 gene contains a conserved consensus SREBP binding site. We were unable to find such sites in the proximal promoter region of the other selected genes. Therefore, we can not exclude that these genes are regulated in an indirect manner. Analysis of the proximal promoter of HMOX1 confirmed the direct regulation by both SREBP-1a and SREBP-1c and led to the identification of one potential regulatory E-box. SREBP-2 was not able to regulate the HMOX1 promoter, by contrast to the classical SREdriven promoter of the HMGCS gene. These results are in line with previous studies showing that SREBP-2 is not able to activate E-box-driven promoters (3). Since SREBP-2 can bind to E-box sequences, at least in gel shift assays, it has been suggested that it is not able to cooperate with cofactors that are essential for transactivation of E-box-driven lipogenic promoters (3).
The site identified in HMOX1 overlaps with a previously described hypoxia-inducible factor (HIF) binding site. Two other genes induced by SREBP-1c in AG01518 cells are also known to be induced by hypoxia: cyclin G2 (data not shown) and GPx-3 (23), but other classical hypoxia response genes, such as VEGF and adrenomedullin, were regulated in an opposite manner (data not shown), indicating that SREBP-1 did not activate HIF in fibroblasts. Whether SREBP can cooperate or compete with HIF on certain gene promoters, such as HMOX1 or GPx-3, should be further studied. Interestingly, yeast SREBP has been
shown to act as an oxygen sensor (24) .
HMOX1 catalyses the degradation of heme into biliverdin, which is subsequently transformed into bilirubin by biliverdin reductase. The latter enzyme may also be regulated by SREBP-1, according to microarray data published by Horton and colleagues (13) . HMOX1, which is up-regulated by different types of cellular stresses, also presents potent antioxidant properties, associated with the release of carbon monoxide, iron and biliverdin from the heme molecule (18, 19) . HMOX1-deficient cells are more sensitive to oxidative stress. Knock-out animals are vulnerable to hepatic necrosis and die when challenged with endotoxin (19) .
Since SREBP-1 over-expression can lead to liver steatosis and stress (25, 26) , we speculate that HMOX1 induction by SREBP-1 may be part of a protective response. In line with this hypothesis, increased HMOX1 expression was observed by Malaguarnera et al in nonalcoholic fatty liver disease patients (27) . Altogether, our data support the hypothesis that SREBPs play a role in stress responses, as previously suggested by Robichon and colleagues, who showed that SREBP-2 regulates the expression of the heat shock protein DNAJA4 (28, 29) . Strikingly, most of the genes that have been reported to be regulated by SREBPs and that are not related to lipid metabolism are involved in stress responses (Table IV) .
Activation of SREBP-1 by insulin and growth factors depends on PI3K, an enzymatic complex composed of a p110 catalytic subunit associated with a regulatory subunit, which acts as an adaptor protein. There are five regulatory subunits for PI3K encoded by three genes: p85α, p55α and p50α are encoded by PIK3R1, p85β by PIK3R2 and p55γ by PIK3R3.
Differences in expression of p85α and β were shown to affect PI3K activation. These regulatory subunits are required for PI3K activation, but when their concentration exceeds that of the catalytic subunit p110, free p85 may compete with PI3K complexes for binding to activated receptors (30, 31) . Therefore, the up-regulation of p55γ may represent a negative or positive feedback mechanism, depending on the local regulatory subunit concentration. It is also possible that p55γ transduces a signal that is slightly different from p85α and β, as p55γ has a unique N-terminal sequence that is able to bind to tubulin (32) and Rb (33) . This is the second example of PI3K regulation by SREBP-1, which was previously shown to decrease the expression of IRS-2 (34), an adaptor protein that is essential for PI3K activation by insulin. Inhibition of IRS-2 expression by SREBP decreases the hepatocyte response to insulin in a negative feedback manner (34) .
The potential roles of SV2A and COTE1 in the SREBP response are unknown. SV2A
is a membrane protein associated with exocytosis in neurones and endocrine cells (17) .
Whether SREBP can regulate certain exocytic processes should be further studied. The COTE1 gene product does not contain any known motif, except four potential transmembrane domains. This hydrophobic protein may play a role in lipid metabolism.
In conclusion, we have identified novel non-classical mediators of the SREBP-1 response, including heme oxygenase 1 and p55γ, further supporting the hypothesis that SREBP-1 regulates stress response and signaling genes. Table II. Potential novel SREBP target genes involved in lipid metabolism.
Significantly regulated genes were selected as described in Significantly regulated genes were selected as described in Mice (6 per group) were fasted for 24 h and then re-fed with a high carbohydrate (HC) diet for 12 h. In the control group, mice were sacrificed after fasting (Ctrl). RNA was extracted from the liver and used for reverse transcription and quantitative PCR analysis. A Student ttest was performed (*, p<0.05; **, p<0.01). 
